Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$83.90 USD
+0.01 (0.01%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $83.92 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | 1.66 |
EPS Last Quarter | 2.01 |
Last EPS Surprise | 24.84% |
ABR | 2.07 |
Earnings ESP
|
-4.72% |
---|---|
Current Year | 3.78 |
Next Year | 7.24 |
EPS (TTM) | 4.70 |
P/E (F1) | 22.21 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.98B | 7.08B | 27.63B | 27.90B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 7.39B | 7.64B | 28.67B | 28.64B |
Low Estimate | 6.79B | 6.50B | 27.05B | 27.30B |
Year ago Sales | 7.05B | 7.12B | 27.12B | 27.63B |
Year over Year Growth Est. | -0.98% | -0.49% | 1.90% | 0.99% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.66 | 1.60 | 3.78 | 7.24 |
# of Estimates | 12 | 10 | 12 | 13 |
Most Recent Consensus | 1.58 | 1.47 | 3.74 | 6.88 |
High Estimate | 1.95 | 2.20 | 3.94 | 7.82 |
Low Estimate | 1.45 | 1.15 | 3.48 | 6.88 |
Year ago EPS | 2.29 | 1.72 | 6.72 | 3.78 |
Year over Year Growth Est. | -27.51% | -6.98% | -43.75% | 91.53% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 2 | 2 |
Up Last 60 Days | 1 | 1 | 8 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 7 | 8 | 3 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.66 | 1.60 | 3.78 | 7.24 |
7 Days Ago | 1.66 | 1.60 | 3.78 | 7.24 |
30 Days Ago | 1.68 | 1.63 | 3.76 | 7.20 |
60 Days Ago | 1.74 | 1.77 | 3.72 | 7.21 |
90 Days Ago | 1.75 | 1.80 | 3.76 | 7.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.58 | 1.47 | 3.86 | 7.16 |
Zacks Consensus Estimate | 1.66 | 1.60 | 3.78 | 7.24 |
Earnings ESP | -4.72% | -7.91% | 2.26% | -1.04% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.01 | -1.32 | 1.72 | 2.29 | NA |
Estimate | 1.61 | -1.49 | 1.76 | 1.91 | NA |
Difference | 0.40 | 0.17 | -0.04 | 0.38 | 0.23 |
Surprise | 24.84% | 11.41% | -2.27% | 19.90% | 13.47% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more